Molecular Designs

Birmingham, United States Founded: 2019 • Age: 7 yrs
Molecular diagnostic kits are developed for detecting various diseases.

About Molecular Designs

Molecular Designs is a Healthcare company based in Birmingham (United States) founded in 2019. Molecular diagnostic kits are developed for detecting various diseases. Molecular Designs has completed 1 acquisition, including Lamda Biotech. Its chief executive, as recorded, is Ted Kramm. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include DermTech, NeuMoDx and Biomeme; 3 of its 3 listed competitors have raised funding.

Company details

Molecular Designs was founded in 2019 in Birmingham, United States, within the biotechnology sector focused on diagnostics. Molecular diagnostic kits are created for identifying a broad spectrum of diseases through established PCR methods. Multiplexed assays are designed to pinpoint pathogens and swiftly detect disease indicators. Test panels are provided to assess infectious diseases, supporting clinical and research applications in the region.

  • Headquarters Birmingham, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website moleculardesigns.com
  • Social LinkedIn
Key Metrics

People of Molecular Designs

21 people are tracked at Molecular Designs (13 in leadership, 8 in team).

NameRoleGroup
Ted Kramm
CEOLeadership
Marty Sampson
IT Director And Security OfficerLeadership
Mark Brown
Vice President Of SalesLeadership
Peyton Hawkins
VP Of OperationsLeadership
Chris C.
Director Of Infrastructure & SecurityLeadership
Todd Speranzo
Chief Commercial Officer (cco)Leadership
Blair Walker
Associate Director Of R&dLeadership
Caroline Canon Becker
HR Business PartnerLeadership
Nicole Kincaid
Human Resource DirectorLeadership
Michael Clark
CEOLeadership
Greer Massey
Chief Scientific OfficerLeadership
Jeslyn Metcalf Nicodemus
Director Of Customer SuccessLeadership
Benton Mahaffey
VP Of FinanceLeadership
Lorena Dittmar
Senior Sales Tax AccountantTeam
Kevin Gillmore
Accounts Payable SpecialistTeam
Lauren Doles
Operations ManagerTeam
Brad Engel
Corporate ControllerTeam
Shamik Das
Senior ScientistTeam
Lara Self
Quality Assurance ManagerTeam
Nathan McWain
Scientist III - Process AnalyticsTeam

1 more people are available in the full profile.

Premium access

Complete people profiles for Molecular Designs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Molecular Designs

Molecular Designs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lamda Biotech.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Kits and assays are supplied to the life science community.
lamdabio.comSaint Louis, United States2006Sep 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for Molecular Designs

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Molecular Designs

2 dated milestones of Molecular Designs across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Molecular Designs is founded.
  2. Acquisition Acquires Lamda Biotech.

Competitors of Molecular Designs

Molecular Designs has 3 listed competitors in our database, 3 of them funded. They include DermTech, NeuMoDx and Biomeme.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dermtech.com1996San Diego, United States$24.37M259
Adhesive patch biopsies for skin cancer detection are provided.
neumodx.com2012Ann Arbor, United States$66.04M125
Developer of a platform for low cost molecular testing
biomeme.com2013Philadelphia, United States$6.2M202
Smartphone-based DNA detection platform is developed for diagnostics.
Premium access

Detailed competitors of Molecular Designs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Molecular Designs

The website of Molecular Designs (moleculardesigns.com) receives about 3.2K visits a month.

  • Monthly visits
    3.2K

    ▲ 11.4% vs previous month

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Molecular Designs (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Molecular Designs

Premium access

Complete news archive for Molecular Designs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Molecular Designs

Molecular Designs was founded in 2019.

Molecular Designs is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.

Ted Kramm is the CEO of Molecular Designs, as recorded in our data.

Molecular Designs was founded in 2019 in Birmingham, United States, within the biotechnology sector focused on diagnostics. Molecular diagnostic kits are created for identifying a broad spectrum of diseases through established PCR methods. Multiplexed assays are designed to pinpoint pathogens and swiftly detect disease indicators. Test panels are provided to assess infectious diseases, supporting clinical and research applications in the region.

Molecular Designs's top competitors include DermTech, NeuMoDx and Biomeme.

Molecular Designs has made 1 acquisition, including Lamda Biotech.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available